aside
SCRIP INTELLIGENCE, A LEADING SOURCE OF NEWS AND STRATEGIC ANALYSIS FOR THE GLOBAL PHARMACEUTICAL INDUSTRY, PUBLISH ARTICLE ABOUT ISOFOL MEDICAL AB’S LEAD CANDIDATE MODUFOLIN®, AND THE UPCOMING PIVOTAL PHASE III STUDY IN METASTATIC COLORECTAL CANCER
John Davis, journalist and editor for more than 30 years, of Scrip Intelligence recently interviewed Anders Rabbe, CEO of Isofol…